COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders – guidance (NG167)
The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection.
Source:
National Institute for Health and Care Excellence